Approx. 50 minutes
Highlights of CROI: Meeting Highlights and Implications for HIV Management
Calvin Cohen, MD
Internal Medicine Physician
Paul E. Sax, MD
Director of the HIV Program and Division of Infectious Diseases
Approx. 50 minutes
Immune Activation and Inflammation--What to Measure and What to Do About It?
David Wohl, MD
Associate Professor of Medicine, UNC School of Medicine
Joseph Eron, MD
Professor of Medicine
Approx. 50 minutes
Novel Treatment Strategies for HIV/AIDS: NRTI Sparing, Monotherapies, and Eradication
Ian Frank, MD
Director of the Clinical-Therapeutics Program
Pablo Tebas, MD
Director, AIDS Clinical Trials Unit (ACTU)
Approx. 50 minutes
New Paradigms for the Treatment of Patients Infected with HCV Genotype 1: Peginterferon Alfa/Ribavirin Combined With HCV Protease Inhibitors
Charles D. Howell, MD
Professor of Medicine, Director of Hepatology Research
Mark S. Sulkowski, MD
Professor of Medicine
Approx. 50 minutes
Maximizing Success and Minimizing Risks: The Role of IL28B Testing and Hepatitis C Viral Kinetics
Andrew J. Muir, MD, MHS
Clinical Director, Hepatology
Ayman Koteish, MD
Assistant Professor of Medicine
David L. Thomas, MD, MPH
Director of the Division of Infectious Diseases
Approx. 50 minutes
Successful Office-Based Management of Patients With HCV Protease Inhibitors and Peginterferon/Ribavirin
K. Rajender Reddy, MD
Professor of Medicine
Mark S. Sulkowski, MD
Professor of Medicine
Sanjeev Arora, MD
Professor of Medicine
Approx. 50 minutes
Keynote Address: The State of Infectious Disease
Featuring John G. Bartlett, MD from Johns Hopkins University School of Medicine.
Approx. 50 minutes
Top 10 Developments in Hepatitis C
Featuring John G. Bartlett, MD and Mark S. Sulkowski, MD from Johns Hopkins University School of Medicine.
Mark S. Sulkowski, MD
Professor of Medicine
Approx. 50 minutes
Top 10 Observations in Clostridium Difficile
Featuring John G. Bartlett, MD and William B. Greenough, MD from Johns Hopkins University School of Medicine.
William B. Greenough, MD
Professor of Medicine
Approx. 50 minutes
Top 10 Vaccine Messages
Featuring John G. Bartlett, MD and Neal Halsey, MD from Johns Hopkins University School of Medicine.
Neal Halsey, MD
Professor
Approx. 50 minutes
Current Trends in Infection Control
Featuring Jonathan M. Zenilman, MD and Trish M. Perl, MD, MSc from Johns Hopkins University School of Medicine.
Jonathan M. Zenilman, MD
Chief, Infectious Diseases Division
Trish M. Perl, MD, MSc
Associate Professor
Approx. 50 minutes
Ten Hot Topics in AIDS/HIV
Featuring Daniel R. Kuritzkes, MD, MS from Harvard Medical School and Paul E. Sax, MD from Brigham & Women’s Hospital.
Daniel R. Kuritzkes, MD, MS
Professor of Medicine
Paul E. Sax, MD
Director of the HIV Program and Division of Infectious Diseases
Approx. 50 minutes
New STD Guidelines From the CDC and Your Patient
Featuring Edward Hook III, MD from University of Alabama, Birmingham and Khalil Ghanem, MD from Johns Hopkins University School of Medicine.
Approx. 60 minutes
Procalcitonin used in Antibiotic Stewardship in Infections
Featuring Eric Howard Gluck, MD from Swedish Covenant Hospital.
*This session is not eligible for AMA PRA Category 1 Credits TM
Sponsored by Siemens
Eric Howard Gluck, MD
Director of Critical Care Services
Approx. 50 minutes
Management of Clostridium difficile-associated diarrhea (CDAD)
Featuring Sherwood Gorbach, MD, Chief Scientific Officer, Senior Vice President, Research and Development for Optimer Pharmaceuticals and Professor at Tufts Medical School.
*This session is not eligible for AMA PRA Category 1 Credits TM
Sponsored by Optimer Pharmaceuticals, Inc.
Sherwood Gorbach, MD
Chief Scientific Officer and Senior Vice President
Approx. 50 minutes
Rapid Molecular Testing and Implications for Antimicrobial Stewardship
Featuring Debra Goff, Pharm.D., FCCP at The Ohio State University College of Pharmacy and Dr. Paul Schreckenberger from Loyola University Medical Center.
*This session is not eligible for AMA PRA Category 1 Credits TM
Sponsored by Cubist
Approx. 50 minutes
HIV Screening: What’s Right for Your Testing Population?
Sponsored by Siemens
Katherine Soreng, Ph.D
Head, Clinical and Scientific Marketing
Approx. 50 minutes
INCIVEK Combination Treatment: An Efficacy and Safety Profile Discussion
Sponsored by Vertex
Steven L. Flamm, MD
Professor of Medicine & Surgery Division of Hepatology
